This information was published on 2026-02-20T12:21:12 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2513278 |
| (220) |
13 Jan 2025
|
| (500) |
Provisions of paragraph 44(3)(b) and/or Reg 4.15A(3)(b) applied.
|
| (511) (510) |
Class 5
Pharmaceutical preparations containing one or more small molecule drugs for the purpose of targeting ion channels, membrane transporters, and related pathways; none of the aforementioned preparations being cosmetics, skincare preparations and vitamin supplements; all of the foregoing excluding biochemical laboratory kits for research activities involving gene cloning and expression Class 42 Medical, pharmaceutical, biopharmaceutical, and chemical research and development services; custom development of pharmaceutical, biopharmaceutical and chemical products; pre-clinical and non-clinical evaluation testing of medical, pharmaceutical, biopharmaceutical, and chemical products |
| (540) | TOPO THERAPEUTICS |
| (550) | Word |
| (730) |
Topo Therapeutics, Inc.
|
| (750) |
Davies Collison Cave Pty Ltd
|
Find out more about publications on the About page.